PLRX

Pliant Therapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Coulie BernardDirector, Officer: President And CEO
$114k89.4k shares
SellJan 20, 2026
$1.28
--
Cummings Keith LamontChief Financial Officer
$31k24k shares
SellJan 20, 2026
$1.28
--
Cheung LilyChief Human Resource Officer
$9.6k7.5k shares
SellJan 20, 2026
$1.28
--
Kuo MinnieChief Operating Officer
$8.9k6.9k shares
SellJan 20, 2026
$1.28
--
Ouimette MikeGeneral Counsel & Corp. Sec'y
$112k10.2k shares
SellJan 22, 2025
$10.99
--
Coulie BernardDirector, Officer: President And CEO
$587k52.4k shares
SellJan 17, 2025
$11.20
--

News

seekingalpha.comPliant Therapeutics, Inc. (PLRX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcriptseekingalpha.comMay 22globenewswire.comPliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meetingglobenewswire.comMay 21globenewswire.comPliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Resultsglobenewswire.comMay 11globenewswire.comPliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conferenceglobenewswire.comMay 6globenewswire.comPliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumorsglobenewswire.comApr 30